Page last updated: 2024-10-31

midazolam and Netherton Syndrome

midazolam has been researched along with Netherton Syndrome in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Netherton Syndrome: Rare autosomal recessive disease with variable expressions. Clinical features of the disease include variable ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; bamboo hair (trichorrhexis invaginata); and ATOPIC DERMATITIS. The disease is caused by mutations in the SPINK5 gene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benzon, H1
Thompson, J1
Nardone, H1
Ohlms, L1
McGill, T1
Holzman, RS1

Other Studies

1 other study available for midazolam and Netherton Syndrome

ArticleYear
Anesthetic considerations in Netherton Syndrome.
    Paediatric anaesthesia, 2012, Volume: 22, Issue:4

    Topics: Anesthesia; Anesthesia, Intravenous; Anesthetics, Dissociative; Anesthetics, Intravenous; Cerumen; E

2012